![]() |
|
|
WE Klunk, DF Covey and JA Ferrendelli
This article has been cited by other articles:
![]() |
E. B. Gonzales, C. L. Bell-Horner, M. A. M. de la Cruz, J. A. Ferrendelli, D. F. Covey, and G. H. Dillon Enantioselectivity of {alpha}-Benzyl-{alpha}-methyl-{gamma}-butyrolactone-Mediated Modulation of Anticonvulsant Activity and GABAA Receptor Function J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 677 - 683. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Hill, P. A. Reddy, D. F. Covey, and S. M. Rothman Inhibition of Voltage-Dependent Sodium Channels by the Anticonvulsant gamma -Aminobutyric Acid Type A Receptor Modulator, 3-Benzyl-3-Ethyl-2-Piperidinone J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1303 - 1309. [Abstract] [Full Text] |
||||
![]() |
K. L. Williams, J. B. Tucker, G. White, D. S. Weiss, J. A. Ferrendelli, D. F. Covey, J. E. Krause, and S. M. Rothman Lactone Modulation of the gamma -Aminobutyric Acid A Receptor: Evidence for a Positive Modulatory Site Mol. Pharmacol., July 1, 1997; 52(1): 114 - 119. [Abstract] [Full Text] |
||||
![]() |
R. A. Gross, D. F. Covey, and J. A. Ferrendelli Voltage-Dependent Calcium Channels as Targets for Convulsant and Anticonvulsant Alkyl-Substituted Thiobutyrolactones J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 686 - 694. [Abstract] [Full Text] |
||||